EXTENTRAK
Bayer Aktiengesellschaft
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88673908 |
| Registration Number | 6058759 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Vanessa A. Ignacio |
| Attorney Docket Number | 2019-0130 00 |
Timeline
| 2019-10-30 | Application Filed |
| 2019-11-03 | Location: NEW APPLICATION PROCESSING |
| 2019-11-03 | Status: Live/Pending |
| 2019-11-08 | Transaction Date |
| 2020-05-19 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Bayer Aktiengesellschaft |
| Entity Statement | aktiengesellschaft |
| Address | Kaiser-Wilhelm-Allee 51373 Leverkusen DE 51373 |
| Legal Entity Type | |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | (Based on Intent to Use) Pharmaceutical preparations for the treatment of cancer(Based on 44(e)) Pharmaceutical preparations for the treatment of cancer |
| GS0051 | Pharmaceutical preparations for the treatment of cancer |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2019-11-02 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-11-03 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-01-06 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-01-13 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2020-01-13 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-01-13 | 6 GNRN O:Outgoing Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2020-01-21 | 7 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2020-01-21 | 8 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2020-01-21 | 9 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2020-01-21 | 10 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-01-21 | 11 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2020-01-27 | 12 ALIE A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-02-03 | 13 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-02-03 | 14 ARAA I:Incoming Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-02-12 | 15 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2020-03-03 | 16 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-03-03 | 17 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2020-05-19 | 18 R.PR A:Allowance for Publication |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 EXTENTRAK 88673908 not registered Live/Pending |
Bayer Aktiengesellschaft 2019-10-30 |
 EXTENTRAK 87614116 not registered Dead/Abandoned |
Loxo Oncology, Inc. 2017-09-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 